Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · IEX Real-Time Price · USD
11.21
-0.79 (-6.58%)
At close: May 17, 2024, 4:00 PM
10.82
-0.39 (-3.48%)
After-hours: May 17, 2024, 4:26 PM EDT
Cidara Therapeutics Market Cap
Cidara Therapeutics has a market cap or net worth of $53.14 million as of May 17, 2024. Its market cap has decreased by -46.21% in one year.
Market Cap
53.14M
Enterprise Value
28.77M
1-Year Change
-46.21%
Ranking
Category
Stock Price
$11.21
Market Cap Chart
Since April 15, 2015, Cidara Therapeutics's market cap has decreased from $203.10M to $53.14M, a decrease of -73.83%. That is a compound annual growth rate of -13.71%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 16, 2024 | 54.70M | -5.69% |
May 15, 2024 | 58.00M | -2.85% |
May 14, 2024 | 59.70M | 3.11% |
May 13, 2024 | 57.90M | 4.32% |
May 10, 2024 | 55.50M | -3.48% |
May 9, 2024 | 57.50M | -3.36% |
May 8, 2024 | 59.50M | -2.94% |
May 7, 2024 | 61.30M | -1.29% |
May 6, 2024 | 62.10M | 8.76% |
May 3, 2024 | 57.10M | -1.21% |
May 2, 2024 | 57.80M | 7.24% |
May 1, 2024 | 53.90M | -1.28% |
Apr 30, 2024 | 54.60M | -2.85% |
Apr 29, 2024 | 56.20M | -2.43% |
Apr 26, 2024 | 57.60M | -2.87% |
Apr 25, 2024 | 59.30M | 5.70% |
Apr 24, 2024 | 56.10M | 19.87% |
Apr 23, 2024 | 46.80M | -0.21% |
Apr 22, 2024 | 46.90M | -23.86% |
Apr 19, 2024 | 61.60M | -5.67% |
Apr 18, 2024 | 65.30M | - |
Apr 17, 2024 | 65.30M | -1.06% |
Apr 16, 2024 | 66.00M | -11.53% |
Apr 15, 2024 | 74.60M | 1.77% |
Apr 12, 2024 | 73.30M | -6.15% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Kezar Life Sciences | 55.86M |
HeartBeam | 54.63M |
Modular Medical | 54.54M |
Milestone Scientific | 54.42M |
Rockwell Medical | 54.27M |
BioLineRx | 52.97M |
Cytosorbents | 52.41M |
Aligos Therapeutics | 51.63M |